Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
9.12
+0.04 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
8.96
-0.16 (-1.75%)
After-hours: Mar 9, 2026, 7:57 PM EDT
Delcath Systems Revenue
In the year 2025, Delcath Systems had annual revenue of $85.23M with 129.08% growth. Delcath Systems had revenue of $20.73M in the quarter ending December 31, 2025, with 37.27% growth.
Revenue (ttm)
$85.23M
Revenue Growth
+129.08%
P/S Ratio
3.72
Revenue / Employee
$546,353
Employees
156
Market Cap
316.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 85.23M | 48.03M | 129.08% |
| Dec 31, 2024 | 37.21M | 35.14M | 1,701.69% |
| Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
| Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
| Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 270.28M |
| Cerus | 206.13M |
| Pacific Biosciences of California | 160.01M |
| Quanterix | 138.90M |
| RxSight | 134.48M |
| Standard BioTools | 85.33M |
| 908 Devices | 56.20M |
| TriSalus Life Sciences | 45.15M |
DCTH News
- 6 days ago - Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology - Business Wire
- 7 days ago - Delcath: Fundamentals Intact, Despite Share Price Weakness - Seeking Alpha
- 11 days ago - Delcath Systems, Inc. (DCTH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Delcath Systems Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 25 days ago - Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call - Business Wire
- 5 weeks ago - Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 6 weeks ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade - Seeking Alpha